|
John Fielding,
CEO
|
Ninewells is taking part in a nationwide clinical trial (IBIS) which is currently underway to assess the efficacy of Tamoxifen in the prevention of breast cancer in women established to be at risk.
The recently completed Breast Cancer Prevention Trial demonstrated that tamoxifen also halved the risk of first developing the disease.
|
|
Albert Graham,
Backyard Pool Drainer
|
The breast cancer prevention drug tamoxifen does not influence cardiovascular risk in healthy women or in women with coronary heart disease, according to a study published in the Jan.
In the recently published results of the Breast Cancer Prevention Trial, tamoxifen reduced the chance of being diagnosed with breast cancer by about 50% in women who were considered to be at high risk for developing breast cancer.
Recently, breast cancer prevention trials with tamoxifen showed a 45% reduction in breast cancer incidence and a decreased occurrence of bone fractures.
|
|
Zhang Xian Qian,
Ex-Olympic Swimmer
|
In the Breast Cancer Prevention Trial (BCPT) and the Study of Tamoxifen and Raloxifene (STAR), the agents studied focused on the estrogen receptor as a key to breast cancer risk.
Archives of Internal Medicine 14th October 2002 Tamoxifen looks promising for breast cancer prevention A new study suggests that women on tamoxifen have a reduced breast cancer risk compared to those on placebo.
STAR is designed to determine whether the osteoporosis prevention and treatment drug Raloxifene (Evista) is as effective as Tamoxifen (Nolvadex) in reducing breast cancer risk.
|
|
Arthur Dawkins,
Astro-physicist
|
Further study of tamoxifen and cognition is needed so that healthy women considering tamoxifen for the primary prevention of breast cancer have comprehensive information about the side effects of the treatment.
|
|
|
